Viral Vectors for COVID-19 Vaccine Development
Vaccine development against SARS-CoV-2 has been fierce due to the devastating COVID-19 pandemic and has included all potential approaches for providing the global community with safe and efficient vaccine candidates in the shortest possible timeframe. Viral vectors have played a central role especia...
Main Author: | Kenneth Lundstrom |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/2/317 |
Similar Items
-
Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave
by: Santos Guzmán-López, et al.
Published: (2022-04-01) -
Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection
by: Po-Wei Liao, et al.
Published: (2021-12-01) -
Viral Vector Vaccine Development and Application during the COVID-19 Pandemic
by: Shaofeng Deng, et al.
Published: (2022-07-01) -
The Vaccine World of COVID-19: India’s Contribution
by: Vivek P. Chavda, et al.
Published: (2022-11-01) -
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
by: Ebenezer Tumban
Published: (2020-12-01)